Oncolytics Biotech Inc. (ONCY) Statistics & Valuation Metrics - Stocknear

Oncolytics Biotech Inc.

NASDAQ: ONCY · Real-Time Price · USD
1.06
-0.02 (-1.85%)
At close: Sep 05, 2025, 3:59 PM
1.06
0.00%
After-hours: Sep 05, 2025, 07:29 PM EDT

Oncolytics Biotech Statistics

Share Statistics

Oncolytics Biotech has 100.18M shares outstanding. The number of shares has increased by 15.37% in one year.

100.18M
15.37%
2.78%
1.78%
98.09M
14,099
1.23%

Short Selling Information

The latest short interest is 2.48M, so 2.48% of the outstanding shares have been sold short.

2.48M
2.48%
2.56%
3.26

Valuation Ratios

The PE ratio is -3.17 and the forward PE ratio is -3. Oncolytics Biotech's PEG ratio is 0.

-3.17
-3
0
84.3
16.81
-3.7
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Oncolytics Biotech.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.18.

2.82
2.82
0.18
-0.03
-0.04
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-1.13M
28
0
n/a

Taxes

130K
-0.41%

Stock Price Statistics

The stock price has increased by 10.65% in the last 52 weeks. The beta is 1.19, so Oncolytics Biotech's price volatility has been higher than the market average.

1.19
10.65%
1.03
0.77
52.7
1,145,301

Income Statement

n/a
n/a
-34.98M
-31.71M
-34.88M
-34.98M
-0.41
Full Income Statement

Balance Sheet

The company has 15.94M in cash and 1.06M in debt, giving a net cash position of 14.88M.

15.94M
1.06M
14.88M
-477.71M
19.97M
12.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -26.97M and capital expenditures -239K, giving a free cash flow of -27.2M.

-26.97M
-239K
-27.2M
-0.36
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

ONCY does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ONCY is $5, which is 371.7% higher than the current price. The consensus rating is "Buy".

$5
371.7%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on May 25, 2018. It was a backward split with a ratio of 2:19.

May 25, 2018
backward
2:19

Scores

-34.61
1